Physician

Brett T Brinker, MD

According to 2025 Medicare claims, Brett Brinker, MD (NPI: 1750347290) practices hematology/oncology in the Grand Rapids-Wyoming-Kentwood, MI market, with the plurality of this provider's patient population coming from Kent, MI. This provider's primary affiliated billing organization is CANCER & HEMATOLOGY CENTERS OF WESTERN MI, P.C. (NPI: 1528018389; TIN: 382777354) and primary practice location at 49503-2563. Brinker is affiliated with the POM ACO (ACO ID: A1297), Trinity Health Integrated Care (ACO ID: A3454), and West Michigan Accountable Care Organization, LLC (ACO ID: A4626), participating under the MSSP model.

Brinker's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 518 traditional Medicare patients, billed 161,378 HCPCS/CPT codes, and received $3,691,956 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,111 prescription claims across 434 beneficiaries totaling $19,997,650 in drug costs, led by Revlimid (Lenalidomide). DME data shows 47 claims. Open Payments data shows 33 records totaling $639,052. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,443,201 to $3,691,956. Similarly, Part D prescription costs have moved sharply higher in recent years, from $3,401,356 to $19,997,650. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $6,974 to $800.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.8M$3.7M2015 Medicare payment: $1,443,201 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,258,790 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,557,868 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,960,519 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,232,231 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,240,568 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,409,549 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,190,492 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,105,557 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,691,956 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015611100,945$1,443,201
2016627176,034$2,258,790
2017512152,067$2,557,868
2018542134,661$2,960,519
2019588135,898$3,232,231
2020503141,806$3,240,568
2021526134,786$3,409,549
2022483147,339$3,190,492
2023515157,497$3,105,557
2024518161,378$3,691,956

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$10.0M$20M2015 Drug cost: $3,401,356 (USD; Tot_Drug_Cst)2016 Drug cost: $3,899,639 (USD; Tot_Drug_Cst)2017 Drug cost: $5,007,472 (USD; Tot_Drug_Cst)2018 Drug cost: $6,211,250 (USD; Tot_Drug_Cst)2019 Drug cost: $7,820,616 (USD; Tot_Drug_Cst)2020 Drug cost: $10,283,867 (USD; Tot_Drug_Cst)2021 Drug cost: $14,524,057 (USD; Tot_Drug_Cst)2022 Drug cost: $15,929,335 (USD; Tot_Drug_Cst)2023 Drug cost: $13,536,472 (USD; Tot_Drug_Cst)2024 Drug cost: $19,997,650 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153913,266$3,401,356
20163382,571$3,899,639
20172972,840$5,007,472
20183192,846$6,211,250
20193172,858$7,820,616
20203143,109$10,283,867
20213373,323$14,524,057
20223273,313$15,929,335
20233433,055$13,536,472
20244344,111$19,997,650

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$2.8K$5.7K2015 Medicare payment: $3,973 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $5,650 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $3,361 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $732 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $5,090 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $1,135 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $1,283 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $273 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $657 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $717 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R46$3,973
2016N/R64$5,650
2017N/R60$3,361
2018N/R42$732
2019N/R60$5,090
2020N/R27$1,135
2021N/R52$1,283
2022N/R23$273
2023N/R45$657
2024N/R47$717

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more219416$90
80053Blood test, comprehensive group of blood chemicals2371,060$10
36415Insertion of needle into vein for collection of blood sample2461,345$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count2441,406$8
83615Lactate dehydrogenase (enzyme) level213587$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide2486,746$4,169,728
PomalystPomalidomide1323,696$2,971,029
LenalidomideLenalidomide1243,472$1,816,678
CalquenceAcalabrutinib Maleate1313,904$1,694,505
ImbruvicaIbrutinib1203,422$1,636,863

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R22$395
J8530Cyclophosphamide; oral, 25 mgNN/R12$263
J8610Methotrexate; oral, 2.5 mgNN/R13$59

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.14$296ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.19$638,756Amgen Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Brett T. Brinker, MD?

Tedicare shows public-source Medicare data for Brett T. Brinker, MD (NPI 1750347290), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brett T. Brinker, MD have ACO affiliation data?

Brett T. Brinker, MD is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297), Trinity Health Integrated Care (MSSP, ACO ID A3454), and West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626).

What billing organization is linked to Brett T. Brinker, MD?

Brett T. Brinker, MD is linked to CANCER & HEMATOLOGY CENTERS OF WESTERN MI, P.C. (billing NPI 1528018389) in the available physician profile data.

Does Brett T. Brinker, MD have Open Payments data?

Brett T. Brinker, MD has 33 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.